JP2005505602A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505602A5
JP2005505602A5 JP2003535751A JP2003535751A JP2005505602A5 JP 2005505602 A5 JP2005505602 A5 JP 2005505602A5 JP 2003535751 A JP2003535751 A JP 2003535751A JP 2003535751 A JP2003535751 A JP 2003535751A JP 2005505602 A5 JP2005505602 A5 JP 2005505602A5
Authority
JP
Japan
Prior art keywords
active agent
liposome
producing
release
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003535751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005505602A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2002/000745 external-priority patent/WO2003032947A2/en
Publication of JP2005505602A publication Critical patent/JP2005505602A/ja
Publication of JP2005505602A5 publication Critical patent/JP2005505602A5/ja
Pending legal-status Critical Current

Links

JP2003535751A 2001-09-06 2002-09-09 予め規定された放出プロファイルを有するリポソーム調剤の製造方法 Pending JP2005505602A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31718701P 2001-09-06 2001-09-06
PCT/IL2002/000745 WO2003032947A2 (en) 2001-09-06 2002-09-09 A method for preparing liposome formulations with a predefined release profile

Publications (2)

Publication Number Publication Date
JP2005505602A JP2005505602A (ja) 2005-02-24
JP2005505602A5 true JP2005505602A5 (enExample) 2006-01-05

Family

ID=23232510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003535751A Pending JP2005505602A (ja) 2001-09-06 2002-09-09 予め規定された放出プロファイルを有するリポソーム調剤の製造方法

Country Status (7)

Country Link
US (2) US20060165766A1 (enExample)
EP (1) EP1429726A2 (enExample)
JP (1) JP2005505602A (enExample)
AU (1) AU2002334358B2 (enExample)
CA (1) CA2460209A1 (enExample)
IL (1) IL160350A0 (enExample)
WO (1) WO2003032947A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060015534A (ko) 2003-04-25 2006-02-17 더 펜 스테이트 리서치 파운데이션 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
US20050129753A1 (en) * 2003-11-14 2005-06-16 Gabizon Alberto A. Method for drug loading in liposomes
US20080063702A1 (en) * 2004-09-09 2008-03-13 Yechezkel Barenholz Liposomal Formulations Comprising an Amphipathic Weak Base Like Tempamine for Treatment of Neurodegenerative Conditions
AU2005281352B2 (en) * 2004-09-09 2011-01-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposomal compositions of glucocorticoid and glucocorticoid derivatives
ATE454884T1 (de) 2004-10-18 2010-01-15 Polymun Scient Immunbio Forsch Liposomale zusammensetzung einen wirkstoff zur relaxierung glatter muskulatur enthaltend, die herstellung dieser zusammensetzung und deren therapeutische verwendung
WO2008109031A2 (en) * 2007-03-02 2008-09-12 Luna Innovations Incorporated Liposome carriers for in vivo delivery of fullerenes
DE102007036294A1 (de) 2007-07-31 2009-02-05 Gea Westfaliasurge Gmbh Vorrichtung und ein Verfahren zum Bereitstellen von Informationen über Tiere beim Durchlaufen eines Tierdurchganges
WO2010041255A2 (en) 2008-10-07 2010-04-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Liposomal systems comprising sphingomyelin
JPWO2010058840A1 (ja) * 2008-11-20 2012-04-19 テルモ株式会社 リポソームからの薬物放出手段および放出性評価法
US20100129430A1 (en) * 2008-11-24 2010-05-27 Stavroula Sofou Liposome drug carriers with ph-sensitivity
BR112013016365A2 (pt) * 2010-12-27 2018-06-26 Terumo Corp composição de lipossoma e processo para produção do mesmo
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
WO2014121235A2 (en) * 2013-02-01 2014-08-07 Zoneone Pharma, Inc. Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexes
KR102310786B1 (ko) 2013-02-01 2021-10-12 존원 파마, 인코포레이티드 리포좀 내로 난수용성 약물의 원격 부하
WO2014153192A1 (en) * 2013-03-14 2014-09-25 Zoneone Pharma, Inc. Pharmaceutical formulations of chelating agents as a metal removal treatment system
CN106999419A (zh) 2014-08-04 2017-08-01 佐尼奥尼制药股份有限公司 远程装载略微水溶性药物至脂质膜泡
CA3050686A1 (en) 2017-01-18 2018-07-26 Temasek Life Sciences Laboratory Limited Hyperstabilized liposomes increase targeting of mitotic cells
JP2020111523A (ja) * 2019-01-09 2020-07-27 国立研究開発法人理化学研究所 機能性ナノ構造体
GB202200962D0 (en) * 2022-01-25 2022-03-09 Cytoseek Ltd Polymer additives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US5972379A (en) * 1995-02-14 1999-10-26 Sequus Pharmaceuticals, Inc. Liposome composition and method for administering a quinolone
EP0825852B1 (en) * 1995-04-18 2004-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
IL140892A0 (en) * 1998-08-12 2002-02-10 Yissum Res Dev Co Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
JP2002543134A (ja) * 1999-04-29 2002-12-17 アルザ・コーポレーション 薬物保持率を改善するためのリポソーム組成物

Similar Documents

Publication Publication Date Title
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
NO20042367L (no) Mikronisert filmdannende pulver omfattende et aktivt stoff
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
AU2002358270A1 (en) Zero-order sustained released dosage forms and method of making the same
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
EP1698329A4 (en) PHARMACEUTICAL NANOTEILS, METHOD FOR THE PRODUCTION THEREOF AND PARENTERALLY APPLIED PRODUCT FROM NANOTEILES
PL378932A1 (pl) Zastosowanie ivermectiny do leczenia schorzeń dermatologicznych
UA88168C2 (uk) Препарат у вигляді таблетки саксагліптину з покриттям і спосіб його виготовлення
HRP20030871A2 (en) Anthranilic acid amides, method for the production therefo, their use as antiarrhytmia agents, and pharmaceutical preparations thereof
ZA200507346B (en) Topical formulation of ivermectin for the treatment of dermatological conditions
WO2004071382A3 (en) Substituted heterocycles
WO2003032947A3 (en) A method for preparing liposome formulations with a predefined release profile
BRPI0407181A (pt) Formulação farmacêutica
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
ZA200510170B (en) Method of reducing the harmful effects of orally or transdermally delivered nicotine
WO2006068890A3 (en) Lipid particles comprising bioactive agents, methods of preparing and uses thereof
AU2003241915A1 (en) Vaporizer, various apparatuses including the same and method of vaporization
AU2001250933A1 (en) Chitosan formulation with azelaic acid and other actives for the treatment of acne
AU2003214683A1 (en) Manufacturing method of monoglyceride sulfonate, toilet soap composition using the same, and manufacturing method of toilet soap composition comprising salt
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
AU2003266965A1 (en) Use of carboxamides for the treatment of tinnitus
WO2004041166A3 (en) Dosage forms containing stabilized choline and method for preparing same
WO2004071386A3 (en) Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use
BRPI0507765A (pt) comprimidos revestidos compressos e sua produção
AU2003240169A1 (en) Dermocosmetic treatment by metabolic phospholipids